Fragment Based Drug Discovery

The effective paradigm of molecular linkers in drug discovery is crucial for obtaining relevant candidate molecules in early-stage drug development. In this study, researchers present DiffLinker, a three-dimensional conditional diffusion model for molecular linker design that is E(3)-equivariant. A synthetically available model called DiffLinker generates molecules from disconnected fragments that include all of the original…